Adaptimmune Therapeutics plc ( ADAP) - Stock Earnings
Stock symbol ADAP is outdated, potentially delisted? Maybe it is available on other exchange?
ADAP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -74.2 million USD | 3.2 million USD |
| 2025Q1 | -47.6 million USD | 7.3 million USD |
| 2025Q2 | -30.3 million USD | 13.7 million USD |
ADAP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -165.5 million USD | 27.1 million USD |
| 2023 | -113.9 million USD | 60.3 million USD |
| 2024 | -70.8 million USD | 178.0 million USD |
ADAP
Price: $0.06
52 week price:
Earnings Per Share: -0.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 237100
Ebitda: 858000Market Capitalization: 14.6 million